Cognitive Function and Dialysis Adequacy

Introduction

Cognitive impairment is highly prevalent among patients undergoing hemodialysis. There are several possible explanations for this, including a high incidence of cerebrovascular disease, medication side effects, anemia, and depression. Recent research indicates that cognitive impairment may also be common in earlier stages of chronic kidney disease (CKD) and becomes more prevalent as kidney function declines. However, it is unclear whether uremia itself significantly contributes to cognitive impairment and whether higher doses of dialysis, which enhance solute clearance, correlate with better cognitive function.

Reduced dialysis doses may be linked to poorer cognitive function in hemodialysis patients, affecting cognitive domains such as attention, mental processing, memory, intelligence, and perceptual-motor skills.

Can Dialysis Cause Cognitive Impairment?

Cognition, the mental process involving reasoning and perception, underpins daily activities. In patients with end-stage renal disease (ESRD) undergoing hemodialysis, cognitive impairment and dementia are common issues. This impairment is not confined to older adults but affects individuals across all age groups.

Cognitive impairment in hemodialysis patients adversely impacts functional independence and behavioral symptoms, leading to poorer outcomes and reduced adherence to medical care and medications. The frequency of cognitive impairment in end-stage renal disease patients ranges from 16 to 38 percent, with severe impairment noted in 71 percent of hemodialysis patients above 55 years. Cognitive impairment in dialysis patients is multifactorial, influenced by factors while increasing dialysis frequency may have potential benefits in improving cognitive function.

What Causes Cognitive Impairment During Dialysis?

There are various potential reasons behind cognitive impairment observed in dialysis patients, spanning from common pathologies seen in the general population like Alzheimer’s disease and vascular issues, to conditions specific to dialysis such as metabolic imbalances and aluminium toxicity. Notably, cognitive decline in dialysis patients could be linked to cerebrovascular disease affecting small blood vessels, a condition common across all stages of chronic kidney disease (CKD).

The cognitive impairment due to cerebrovascular disease often results from a long-term cardiovascular disease environment, leading to multiple subtle vascular injuries that initially manifest as mild cognitive impairment, particularly in domains of executive function. Executive functions involve critical cognitive processes such as planning, abstract thinking, and cognitive flexibility, which are crucial for managing a complex chronic condition like kidney disease.

Various other causes may include

• Stroke history.

• Recurrent cerebral ischemia.

• Vertebrobasilar infarcts.

• White matter disease.

• Cerebral edema.

• Oxidative stress.

• Uremia or uremic toxins.

• Aluminium toxicity.

• Age.

• Dyslipidemia.

• Genetic factors like APOE4 allele.

What Cognitive Problems Can Occur in Kidney Disease and Dialysis Patients?

Delirium: It is an acute confusional state that affects global cognition and can occur in about 30 percent of hospitalized elderly patients. It is characterized by:

• Acute Disturbances of Consciousness: Patients experience a sudden decline in awareness and attention.

• Impaired Attention: Difficulty in maintaining concentration or shifting attention.

• Cognitive Changes: Memory loss, disorientation (not knowing where they are or the time of day), and language disturbances (difficulty speaking or understanding language).

• Reversed Sleep-Wake Cycle: Disrupted sleep patterns, with patients awake at night and sleepy during the day.

• Psychotic Features: In some cases, delusions (false beliefs) or hallucinations (seeing or hearing things that are not present) can occur.

Dementia: Dementia refers to chronic cognitive impairment that significantly affects daily life. It is associated with increased risk of delirium due to:

• Low Brain Reserve: Dementia represents a state of diminished cognitive reserve or the ability to cope with raised damage with proper functioning, making the brain more susceptible to acute insults.

• Dementia is characterized by progressive cognitive decline, including:

• Memory loss- difficulty remembering recent events or information.

• Impaired judgment and reasoning- difficulty in decision-making or problem-solving.

• Challenges in speaking, finding the right words, or understanding others,

• Personally or behavior changes, agitation, or social withdrawal.

Dialysis-Related Cognitive Issues:

In patients undergoing dialysis, several specific cognitive issues can arise due to the unique challenges of the treatment process:

• Dialysis Disequilibrium Syndrome: Characterized by confusion and other symptoms resembling delirium, potentially caused by rapid shifts in fluid, urea, and electrolytes during dialysis sessions.

• Acute Cardiovascular Changes: Fluctuations in blood pressure, rapid removal of fluids, and hemoconcentration can lead to cerebral hypoperfusion, contributing to acute confusion or delirium.

• Impact on Cognitive Function: Dialysis patients may experience cognitive impairments related to recurrent delirium episodes or chronic conditions such as cerebrovascular disease, which can manifest as executive function deficits (for example: planning, problem-solving, cognitive flexibility).

Memory Loss: This refers to a condition where individuals experience difficulties in recalling information or events, impacting their daily functioning. It can manifest in various ways:

• Short and long-term memory loss, affecting the ability to retain recent or past information.

• It can be caused due to aging, neurological conditions, medication, and emotional factors.

• Memory loss impacts daily activities and safety, as individuals may struggle with tasks requiring memory, such as remembering appointments or following instructions.

Cognitive Decline: This involves a progressive deterioration in cognitive abilities, impacting thinking, reasoning, and memory. It involves:

• Types: Differentiates between mild cognitive impairment, where cognitive changes are noticeable but do not significantly interfere with daily life, and dementia, where cognitive impairments are severe enough to affect daily functioning.

• Causes: Neurodegenerative disorders like Alzheimer’s or Parkinson’s disease, vascular factors like stroke, traumatic brain injury, and certain medical conditions can contribute to cognitive decline.

• Symptoms: Symptoms include memory loss, impaired judgment, language problems, and behavioral changes.

What Is the Peritoneal Dialysis Adequacy Test?

Dialysis adequacy is defined as providing sufficient dialysis to alleviate uremic symptoms in patients. In peritoneal dialysis (PD), adequacy is often evaluated using metrics such as weekly Kt/Vurea or weekly creatinine clearance (CLcr). Both metrics consider contributions from the peritoneal and residual kidney function:

• Total Kt/Vurea: Combined peritoneal and renal Kt/Vurea to assess overall dialysis adequacy.

• Total CLcr: Sum of peritoneal and renal CLcr, crucial for evaluating clearance efficiency.

Traditionally, Kt/Vurea has been widely used to gauge adequacy, with target ranges typically set between 1.7 to 2.0 weekly. Calculations of Kt/Vurea can be influenced by variations in total body water, which differ by gender and body weight. This can sometimes lead to misconceptions about dialysis adequacy, particularly in overweight patients where higher total body water may incorrectly suggest lower Kt/Vurea values.

To address these challenges, many centers now incorporate weekly CLcr alongside Kt/Vurea assessments. Clinical management should prioritize individualized patient assessments over strict adherence to numeric targets. This approach allows for tailored adjustments to dialysis prescriptions based on clinical response and patient-specific needs rather than solely relying on standardized calculations that may not fully capture the clinical context.

Conclusion:

The relationship between cognitive function and dialysis remains multifactorial. Cognitive impairment significantly affects CKD and dialysis patients, driven largely by ischemic cerebrovascular disease and microvascular pathology. Dialysis procedures may exacerbate acute cerebral ischemia and induce delirium. Doctors should be aware of these effects on daily function and quality of life and suggest potential changes for pre-dialysis cognitive assessments to improve patient care.